Tag Archives | $GHDX

Major League Baseball’s Embarrassment: Dark Money

Last week the Washington Post reported on Major League Baseball’s embarrassment and backtracking over its political contributions to Congressman Jason Lewis (R). According to the Post, Lewis had lamented the fact white Americans are not reproducing at the same rate as Latinos. He suggested abolishing slavery was an overreach by the federal government. He said female voters who care about abortion and same-sex marriage are “nonthinking.” The Congressman has a long history of racist and misogynistic remarks. Continue Reading →

Continue Reading ·

Genomic Health 2018: Will Baker Bros Vote Proxy Access?

Genomic Health 2018 annual meeting is June 6. Will 40% owner Baker Brothers Advisors LP allow proxy access? Genomic Health (GHDX) provides actionable genomic information to personalize cancer treatment decisions worldwide. If Baker Brothers eventually hopes to sell its shares into the market, they would do well to vote for proxy access. Other shareholders will pay a premium for shares of a company with proxy access and other corporate governance provisions that enhance board accountability.

Most shareholders do not vote because reading through 20+ pages of the proxy is not worth the time for the small difference your vote will make, especially when one shareholder has such control. Below, I tell you how I am voting and why.

If you have read these posts related to my portfolio for the last 22 years, have values aligned with mine, and trust my judgment (or you don’t want to take the time to read it), go immediately to see how I voted my ballot. Voting will take you only a minute or two and every vote counts.

I voted with the Board’s recommendations 25% of the time. View Proxy Statement via SEC’s EDGAR system (look for DEF 14A). Continue Reading →

Continue Reading ·

Genomic Health Proxy Voting Guide

Genomic Health proxy 2017Genomic Health Proxy Voting Guide by CorpGov.net. Genomic Health (GHDX), a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions.  Genomic Health is one of the stocks in my portfolio. ProxyDemocracy.org had collected the votes of no fund family when I checked and voted. Their annual meeting is coming up on June 15, 2017.

I voted FOR #5 proxy access, proposed by me. See how and why I voted this and other items below. I voted with the Board’s recommendations 62% of the time. View proxy via SEC’s EDGAR system (look for DEF 14A). Continue Reading →

Continue Reading ·

Genomic Health Inc – Vote Proxy Access

Genomic Health IncGenomic Health Inc GHDX $GHDX, a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. Their annual meeting is coming up on June 9, 2016.

ProxyDemocracy.org had collected the votes of one fund family when I checked. Vote AGAINST pay, compensation committee, stock plan; FOR proxy access. I voted with the Board’s recommendations 45% of the time. View Proxy Statement via iiWisdom. Continue Reading →

Continue Reading ·

Genomic Health: Proxy Score 60

Genomic HealthGenomic Health, Inc. (NASD:GHDX), one of the stocks in my portfolio, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Their annual meeting is coming up on 6/11/2015. ProxyDemocracy.org had the vote of one fund when I checked and voted on 6/9/2015. I also included CalSTRS vote in the table below.  I voted with management 60% of the time and assigned Genomic Health a proxy score of 60. Continue Reading →

Continue Reading ·

Genomic Health $GHDX Proxy Recommendations

GHDXGenomic Health (GHDX), is one of the stocks in my portfolio. Their annual meeting is coming up on June 6, 2014. ProxyDemocracy.org had collected the votes of one fund when I checked and voted on 5/27/2014.  I voted with management 92% of the time.  View Proxy Statement. (Note: GHDX proxy Table of Contents is only for stock incentive plan… not the proxy. Very poorly done.) Read Warnings below. What follows are my recommendations on how to vote the GHDX proxy in order to enhance corporate governance and long-term value.  Continue Reading →

Continue Reading ·

Powered by WordPress. Designed by WooThemes